If the buprenorphine dose is inadequate as well as the CYP3A4 inducer cannot be diminished or discontinued, changeover the individual again into a buprenorphine formulation that allows dose changes. pentobarbital will minimize the level or influence of doxorubicin by affecting hepatic/intestinal